# Characterization Immunology, Biochemical and Lung Microbiome, Correlated With the Ventilation Associated Pneumonia (VAP)

> **NCT04944823** · — · UNKNOWN · sponsor: **Universidad de la Sabana** · enrollment: 50 (estimated)

## Conditions studied

- Covid19
- SARS-CoV Infection

## Interventions

- **OTHER:** Clinical follow-up for 24 months

## Key facts

- **NCT ID:** NCT04944823
- **Lead sponsor:** Universidad de la Sabana
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2022-04
- **Final completion:** 2023-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04944823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04944823, "Characterization Immunology, Biochemical and Lung Microbiome, Correlated With the Ventilation Associated Pneumonia (VAP)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04944823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*